PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för indacaterol. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

25 hits

Bibliografisk träff 2012-11-01

Comparison of indacaterol with tiotropium or twice-daily long-acting β -agonists for stable COPD: a systematic review.

Rodrigo GJ, Neffen H.

Chest · comparative study; research support, non-u.s. gov't; systematic review; journal article · DOI 10.1378/chest.11-2252

Bibliografisk träff 2012-09-01

Limitations of model based dose selection for indacaterol in patients with chronic obstructive pulmonary disease.

Wang Y, Lee JY, Michele T, Chowdhury BA, Gobburu JV.

Int J Clin Pharmacol Ther · meta-analysis; journal article · DOI 10.5414/cp201758

Bibliografisk träff 2012-08-04

An investigation into the structure-activity relationships associated with the systematic modification of the β(2)-adrenoceptor agonist indacaterol.

Beattie D, Beer D, Bradley ME, Bruce I, Charlton SJ, Cuenoud BM, Fairhurst RA, Farr D, Fozard JR, Janus D, Rosethorne EM, Sandham DA, Sykes DA, Trifilieff A, Turner KL, Wissler E.

Bioorg Med Chem Lett · journal article · DOI 10.1016/j.bmcl.2012.07.096

Bibliografisk träff 2012-08-01

Systemic pharmacokinetics of indacaterol, an inhaled once-daily long-acting beta2-agonist, in different ethnic populations.

Matsushima S, Matthews I, Woessner R, Pinault G, Hara H, Wilkins J, Sekiguchi K.

Int J Clin Pharmacol Ther · journal article · DOI 10.5414/cp201719

Bibliografisk träff 2012-07-05

Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis.

Cope S, Kraemer M, Zhang J, Capkun-Niggli G, Jansen JP.

Int J Chron Obstruct Pulmon Dis · research support, non-u.s. gov't; research-article; network meta-analysis; journal article · DOI 10.2147/copd.s31526

Bibliografisk träff 2012-06-25

Efficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysis.

Cope S, Zhang J, Williams J, Jansen JP.

BMC Pulm Med · research support, non-u.s. gov't; research-article; systematic review; network meta-analysis; journal article · DOI 10.1186/1471-2466-12-29

Bibliografisk träff 2012-06-22

Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium.

Beeh KM, Beier J, Donohue JF.

Respir Res · meta-analysis; comparative study; research support, non-u.s. gov't; review-article; journal article · DOI 10.1186/1465-9921-13-52

Bibliografisk träff 2012-06-08

A year in review: new drugs for older adults in 2011.

Vande Griend JP, Marcum ZA, Linnebur SA.

Am J Geriatr Pharmacother · research-article; review; journal article; research support, n.i.h., extramural · DOI 10.1016/j.amjopharm.2012.05.003

Bibliografisk träff 2012-05-30

Metabolism and pharmacokinetics of indacaterol in humans.

Kagan M, Dain J, Peng L, Reynolds C.

Drug Metab Dispos · clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1124/dmd.112.046151

Bibliografisk träff 2012-05-18

Pharmacology and therapeutics of bronchodilators.

Cazzola M, Page CP, Calzetta L, Matera MG.

Pharmacol Rev · review; journal article · DOI 10.1124/pr.111.004580

Bibliografisk träff 2012-05-01

▾Indacaterol for COPD.

Författaruppgift saknas

Drug Ther Bull · journal article · DOI 10.1136/dtb.2012.05.0105

Bibliografisk träff 2012-04-27

Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison.

Mahler DA, D'Urzo A, Bateman ED, Ozkan SA, White T, Peckitt C, Lassen C, Kramer B, INTRUST-1 and INTRUST-2 study investigators.

Thorax · comparative study; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1136/thoraxjnl-2011-201140

Bibliografisk träff 2012-04-12

Indacaterol: a novel long-acting β(2) -agonist.

Ray SM, McMillen JC, Treadway SA, Helmer RS, Franks AS.

Pharmacotherapy · review; journal article · DOI 10.1002/j.1875-9114.2012.01025.x

Bibliografisk träff 2012-04-11

Efficacy of once-daily indacaterol relative to alternative bronchodilators in COPD: a patient-level mixed treatment comparison.

Cope S, Capkun-Niggli G, Gale R, Lassen C, Owen R, Ouwens MJ, Bergman G, Jansen JP.

Value Health · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1016/j.jval.2012.01.009

Bibliografisk träff 2012-04-04

Indacaterol: a new long-acting β2-agonist in the management of chronic obstructive pulmonary disease.

Steiropoulos P, Papanas N, Nena E, Bouros D.

Expert Opin Pharmacother · journal article · DOI 10.1517/14656566.2012.674513

Bibliografisk träff 2012-04-01

Slow receptor dissociation is not a key factor in the duration of action of inhaled long-acting β2-adrenoceptor agonists.

Sykes DA, Charlton SJ.

Br J Pharmacol · research-article; journal article · DOI 10.1111/j.1476-5381.2011.01639.x

Bibliografisk träff 2012-03-27

Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts.

Tannheimer SL, Wright CD, Salmon M.

Respir Res · research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/1465-9921-13-28

Bibliografisk träff 2012-03-05

Comparative efficacy of indacaterol in chronic obstructive pulmonary disease.

Ribeiro M, Chapman KR.

Int J Chron Obstruct Pulmon Dis · research support, non-u.s. gov't; review-article; review; journal article · DOI 10.2147/copd.s19805

Bibliografisk träff 2012-03-01

Indacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease.

McKeage K.

Drugs · review; journal article · DOI 10.2165/11208490-000000000-00000

Bibliografisk träff 2012-02-25

Validation of an on-line solid-phase extraction method coupled to liquid chromatography-tandem mass spectrometry detection for the determination of Indacaterol in human serum.

Emotte C, Heudi O, Deglave F, Bonvie A, Masson L, Picard F, Chaturvedi A, Majumdar T, Agarwal A, Woessner R, Kretz O.

J Chromatogr B Analyt Technol Biomed Life Sci · journal article · DOI 10.1016/j.jchromb.2012.02.025

Bibliografisk träff 2012-02-01

Efficacy and safety of indacaterol 150 and 300 µg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: a 12-week, placebo-controlled study.

Kinoshita M, Lee SH, Hang LW, Ichinose M, Hosoe M, Okino N, Prasad N, Kramer B, Fukuchi Y, Indacaterol Asian COPD Study Investigators.

Respirology · comparative study; multicenter study; randomized controlled trial; journal article · DOI 10.1111/j.1440-1843.2011.02107.x

Bibliografisk träff 2011-11-18

Therapeutic potential for novel ultra long-acting β2-agonists in the management of COPD: biological and pharmacological aspects.

Malerba M, Radaeli A, Morjaria JB.

Drug Discov Today · review; journal article · DOI 10.1016/j.drudis.2011.11.002

Bibliografisk träff 2011-10-27

Acute effects of indacaterol on lung hyperinflation in moderate COPD: a comparison with tiotropium.

Rossi A, Centanni S, Cerveri I, Gulotta C, Foresi A, Cazzola M, Brusasco V.

Respir Med · comparative study; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.rmed.2011.09.006

Bibliografisk träff 2011-10-20

From libraries to candidate: the discovery of new ultra long-acting dibasic β₂-adrenoceptor agonists.

Alcaraz L, Bailey A, Cadogan E, Connolly S, Jewell R, Jordan S, Kindon N, Lister A, Lawson M, Mullen A, Dainty I, Nicholls D, Paine S, Pairaudeau G, Stocks MJ, Thorne P, Young A.

Bioorg Med Chem Lett · journal article · DOI 10.1016/j.bmcl.2011.10.049

Bibliografisk träff 2011-07-11

Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis.

Wang J, Nie B, Xiong W, Xu Y.

J Clin Pharm Ther · meta-analysis; comparative study; review; journal article · DOI 10.1111/j.1365-2710.2011.01285.x